{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:34:47Z","timestamp":1792128887202,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/dmd.124.001497","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:25:14Z","timestamp":1728314714000},"page":"100004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Utilization of a human Liver Tissue Chip for drug-metabolizing enzyme induction studies of perpetrator and victim drugs"],"prefix":"10.1016","volume":"53","author":[{"given":"Shivam","family":"Ohri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paarth","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiny Amala Priya","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Cirit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001497_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002280050420","article-title":"The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin","volume":"54","author":"Backman","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C9LC00768G","article-title":"Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry","volume":"20","author":"Baudy","year":"2020","journal-title":"Lab Chip"},{"key":"10.1124\/dmd.124.001497_bib3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/dmd.115.069096","article-title":"Evaluation of a new molecular entity as a victim of metabolic drug-drug interactions-an industry perspective","volume":"44","author":"Bohnert","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/dmd.113.053397fullarticlecorrection","article-title":"Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac","volume":"47","author":"Chan","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis","volume":"23","author":"Dechanont","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1124\/dmd.124.001497_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1208\/s12248-014-9691-7","article-title":"Addressing the challenges of low clearance in drug research","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J"},{"key":"10.1124\/dmd.124.001497_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1039\/C6LC01374K","article-title":"Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip","volume":"17","author":"Du","year":"2017","journal-title":"Lab Chip"},{"key":"10.1124\/dmd.124.001497_bib8","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/s41598-018-22749-0","article-title":"Interconnected microphysiological systems for quantitative biology and pharmacology studies","volume":"8","author":"Edington","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.124.001497_bib9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1124\/dmd.110.033126","article-title":"Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes","volume":"38","author":"Fahmi","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1039\/C9LC00857H","article-title":"Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization","volume":"20","author":"Fowler","year":"2020","journal-title":"Lab Chip"},{"key":"10.1124\/dmd.124.001497_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0009-9236(03)00187-5","article-title":"The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity","volume":"74","author":"Gorski","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001497_bib12","first-page":"1","article-title":"Prescription drug use continues to increase: U.S. Prescription drug data for 2007-2008","volume":"42","author":"Gu","year":"2010","journal-title":"NCHS Data Brief"},{"key":"10.1124\/dmd.124.001497_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2125.1983.tb02218.x","article-title":"Induction of propranolol metabolism by rifampicin","volume":"16","author":"Herman","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib14","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1021\/acs.molpharmaceut.6b00396","article-title":"Use of H\u03bcREL human coculture system for prediction of intrinsic clearance and metabolite formation for slowly metabolized compounds","volume":"13","author":"Hultman","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001497_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2008.03120.x","article-title":"The recovery time-course of CYP3A after Induction by St John\u2019s Wort Administration","volume":"65","author":"Imai","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1124\/dmd.118.081927","article-title":"Considerations from the innovation and quality induction working group in response to drug-drug interaction guidances from regulatory agencies: focus on CYP3A4 mRNA in\u00a0vitro response thresholds, variability, and clinical relevance","volume":"46","author":"Kenny","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.124.001497_bib18","doi-asserted-by":"crossref","first-page":"15714","DOI":"10.1073\/pnas.0906820106","article-title":"Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance","volume":"106","author":"Kidambi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.124.001497_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12248-016-0019-7","article-title":"Metabolic profiling of human long-term liver models and hepatic clearance predictions from in\u00a0vitro data using nonlinear mixed-effects modeling","volume":"19","author":"Kratochwil","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/dmd.124.001497_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2125.2008.03201.x","article-title":"Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping","volume":"66","author":"Link","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog","volume":"134","author":"Lu","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.124.001497_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bdd.2212","article-title":"In\u00a0vitro and in\u00a0vivo methods to assess pharmacokinetic drug\u2013drug interactions in drug discovery and development","volume":"41","author":"Lu","year":"2020","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.124.001497_bib23","article-title":"Liver-on-chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1124\/dmd.124.001497_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1124\/dmd.124.001497_bib25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1124\/dmd.106.009878","article-title":"In\u00a0vitro and in\u00a0vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies","volume":"34","author":"Prueksaritanont","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1208\/s12248-023-00870-x","article-title":"A\u00a0novel milli-fluidic Liver Tissue Chip with continuous recirculation for predictive pharmacokinetics applications","volume":"25","author":"Rajan","year":"2023","journal-title":"AAPS J"},{"key":"10.1124\/dmd.124.001497_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/clpt.2010.271","article-title":"Rifampin\u2019s acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug\u2013drug interaction trial design","volume":"89","author":"Reitman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001497_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/cpt.2259","article-title":"Do inhibitory metabolites impact DDI risk assessment? Analysis of in\u00a0vitro and in\u00a0vivo data from NDA reviews between 2013 and 2018","volume":"110","author":"Steinbronn","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001497_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/psp4.12110","article-title":"Quantitative prediction of drug\u2013drug interactions involving inhibitory metabolites in drug development: how can physiologically based pharmacokinetic modeling help?","volume":"5","author":"Templeton","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib30","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1208\/s12248-017-0122-4","article-title":"Integrated gut and liver microphysiological systems for quantitative in\u00a0vitro pharmacokinetic studies","volume":"19","author":"Tsamandouras","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/dmd.124.001497_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00228-018-2450-4","article-title":"Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries","volume":"74","author":"van Dyk","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001497_bib32","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1021\/acs.analchem.9b02224","article-title":"Analysis of an integrated human multiorgan microphysiological system for combined tolcapone metabolism and brain metabolomics","volume":"91","author":"Wang","year":"2019","journal-title":"Anal Chem"},{"key":"10.1124\/dmd.124.001497_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.apsb.2016.07.012","article-title":"An update on the role of intestinal cytochrome P450 enzymes in drug disposition","volume":"6","author":"Xie","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.124.001497_bib34","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1124\/dmd.111.038067","article-title":"Simulation of clinical drug-drug interactions from hepatocyte CYP3A4 induction data and its potential utility in trial designs","volume":"39","author":"Xu","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001497_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.124.001497_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2125.2003.01728.x","article-title":"The distribution and gender difference of CYP3A activity in Chinese subjects","volume":"55","author":"Zhu","year":"2003","journal-title":"Br J Clin Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:36:01Z","timestamp":1761194161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624148441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0090955624148441"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001497","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.17.603946","asserted-by":"object"}]},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of a human Liver Tissue Chip for drug-metabolizing enzyme induction studies of perpetrator and victim drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100004"}}